XYNOVAETHRIX – INVESTOR & SPONSOR CHARTER

1. Purpose

This Investor & Sponsor Charter ("Charter") governs the rights, responsibilities, and obligations of investors, sponsors, and strategic partners of XYnovaethrix and its affiliated entities. It ensures transparency, trust, and alignment with global standards for investment, sponsorship, and financial engagement.

---

2. Scope

This Charter applies to: - Equity investors, angel investors, venture partners - Sponsorship partners and corporate collaborators - Revenue-sharing or strategic partnership agreements - All global jurisdictions where XYnovaethrix operates

It complements: - Revenue & Trust Framework - Risk, Liability & Platform Immunity Policy - Subscription, Payment & Refund Terms - Advertising & Partner Policy

---

3. Rights and Benefits

Investors and sponsors are entitled to: - Access to audited financial reports and transparency summaries - Participation in scheduled briefings and strategic updates - Precedence in future investment or partnership opportunities - Recognition in official communications, subject to approval - Dividend, revenue-sharing, or sponsor benefit structures defined in agreements

---

4. Obligations

Investors and sponsors must: - Comply with applicable laws and regulatory requirements - Respect confidentiality and non-disclosure agreements - Avoid conflicts of interest or activities that harm XYnovaethrix - Submit necessary documentation for AML/KYC verification - Follow reporting and communication protocols

---

5. Investment & Revenue Framework

- Terms of investment, equity, or sponsorship are documented in formal agreements - Revenue-sharing, profit distribution, or sponsorship benefits follow mutually agreed formulas - Founder and executive oversight ensures compliance with global accounting standards and trust frameworks

---

6. Governance Participation

- Investors may be invited to advisory boards or committees - Voting rights, where applicable, are defined per agreement - Founder retains ultimate control and override rights in strategic decisions

---

7. Risk & Liability

- Investors and sponsors acknowledge the inherent risks of digital platform operations - XYnovaethrix limits liability according to the Risk, Liability & Platform Immunity Policy - No guarantees of financial returns unless explicitly documented

---

8. Reporting & Transparency

- Regular reporting of platform metrics, revenue, and major operational changes - Transparency summaries are provided to maintain confidence and regulatory compliance - Detailed internal reporting is available only to authorized executives and founder

---

9. Dispute Resolution

- Internal escalation and arbitration procedures apply to disputes - Jurisdiction is defined per entity charter or global operating region - Founder has authority for final override in critical disputes

---

10. Classified Internal Addendum (Not Public)

Includes: - Detailed revenue splits, investment valuations, and contractual terms - Founder emergency override powers and succession authority - Confidential investor and sponsor lists - Strategic risk exposure and mitigation plans - Sensitive negotiations, legal contingencies, and high-level agreements

---

11. Amendments

This Charter may be updated periodically. Continued engagement constitutes acceptance of revisions.

---

Last Updated: [Insert Date]